Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001010519 | SCV001170733 | benign | Hereditary cancer-predisposing syndrome | 2022-08-20 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001043640 | SCV001207396 | benign | Retinoblastoma | 2025-01-08 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005012442 | SCV005636562 | uncertain significance | Bone osteosarcoma; Malignant tumor of urinary bladder; Small cell lung carcinoma; Retinoblastoma | 2024-06-18 | criteria provided, single submitter | clinical testing |